Famed AIDS Researcher Is Racing to Find a Coronavirus Treatment

Columbia’s David Ho is leading a group that’s trying to compress a five-year process into one.

Yaoxing Huang, David Ho, and Sho Iketani.

Yaoxing Huang, David Ho, and Sho Iketani.

Photographer: Samantha Casolari for Bloomberg Businessweek

It seems obvious now that David Ho, arguably the world’s most famous AIDS researcher, would get involved in seeking a treatment for Covid-19, the disease caused by the new coronavirus. It seems obvious that he would redirect the work of his several dozen scientists at the Aaron Diamond AIDS Research Center. That he would, as he says, “rob Peter to pay Paul” to get started with funds meant for the lab’s HIV studies. That he would receive $2.1 million from the Jack Ma Foundation in Hangzhou, China, without even asking and an additional $6 million from other private donors, among them a few very concerned businesspeople.

But in late December, when Ho was tracking reports of a few cases of unexplained pneumonia in Wuhan, it wasn’t obvious he’d be needed. “We were paying attention but didn’t think we would get involved. It seemed rare—and over there,” he says. In early January, as his lab changed its affiliation from Rockefeller University to Columbia University and moved to Upper Manhattan, the situation in Wuhan had become worse. Ho still wasn’t sure if he should get involved. “The scientists in China were already doing so much,” he says. Many of those scientists, in Beijing, Hong Kong, and Shanghai, are former students of his. “They could very well do the job.”